Company / EPS (Diluted)
MUSTANG BIO, INC. EPS (Diluted) History
FY2016-FY2019 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest EPS (Diluted)
-$1.14
FY2019
5-year range
-$1.24 / -$0.45
FY2016-FY2019
Trend
+8.1%
vs FY2018
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Declined from $-0.45 to $-1.14 over the past 2 years.
Based on SEC 10-K filings.
-1.14 in FY2019.
Declined from $-0.45 to $-1.14 over the past 2 years.
EPS (Diluted) over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2019, eps (diluted) increased 8.1% year-over-year.
Company context
Key Data Points
- Altman Z-Score -0.37 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | EPS (Diluted)Value | YoY GrowthYoY |
|---|---|---|
| FY2019 | -$1.14 | +8.1% |
| FY2018 | -$1.24 | -175.6% |
| FY2017 | -$0.45 | +0.0% |
| FY2016 | -$0.45 | - |
As of FY2019 · SEC 10-K · Updated Jun 24, 2026